PMVP
$1.56
PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule therapies targeting p53 mutations and other p53-related cancers in the United States.
Intraday
Recent News
CarMax Stock Down 47% This Past Year, But One Fund Is Betting $6 Million on a Turnaround
CarMax runs a nationwide network of used car stores and digital channels, offering multi-channel sales and financing to U.S. consumers.
Alumis Stock Has Rallied 250% This Past Year. One Fund Sold Its $5 Million Stake Last Quarter.
This clinical-stage biotech develops therapies targeting autoimmune and neuroinflammatory diseases with a focus on TYK2 inhibition.
Caesarstone And 2 More Penny Stocks Worth Watching
As the U.S. market faces fluctuations with major indices like the Dow Jones and S&P 500 experiencing declines, investors are increasingly seeking alternative opportunities to diversify their portfolios. Penny stocks, a term that may seem outdated, continue to hold potential for those willing to explore smaller or newer companies that can offer growth at lower price points. With strong balance sheets and solid fundamentals, these stocks can present hidden gems in today's market landscape,...
Top Penny Stocks To Watch In November 2025
As the U.S. market experiences a downturn with major indexes like the Dow Jones dropping significantly, investors are seeking opportunities that can weather current uncertainties. Penny stocks, though an older term, remain relevant for those looking to invest in smaller or newer companies that might offer unique growth prospects. By focusing on penny stocks with strong financial health, investors can potentially uncover hidden gems amidst market volatility.
Is PMV Pharmaceuticals (NASDAQ:PMVP) In A Good Position To Deliver On Growth Plans?
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, biotech and mining...